Revenue
attach_money292M USD
YoY +43.7%
XERSXeris Biopharma Holdings, Inc.$ --
Xeris Biopharma Holdings, Inc.
XERS
$ -
-
You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.
analyticsIncome Statement Summary
FY2025 Full YearUpdated: 12/31/2025
Operating Income
bar_chart25M USD
YoY +174.0%
Net Income
verified1M USD
YoY +101.0%
EPS
pie_chart0USD
YoY +100.9%
Quarterly Performance
Quarterly revenue and net income trend
RevenueOperating IncomeNet Income
No quarterly data available
Full-Year Progress
Net Income Progress11.7%Below Target
Revenue Progress83.1M
Revenue Forecast384M
Net Income Progress2.2M
Net Income Forecast19M
Income Statement Details
Item
Revenue
Cost of revenue
Gross profit
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
Interest expense
Income before tax
Income tax expense
Net income
Unlock Long-Term Income Statement Data
Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.